ClinicalTrials.govpublic full text
First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer
hepatocellular carcinoma, liver cancer, oligonucleotide, rna, sarna, sorafenib, myeloid, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803919
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.